Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) released a new version of its Medical Education Suite, an artificial intelligence (AI)-powered platform designed to enhance healthcare education for learners and teachers, as announced in a news release.
The product enhances the clinical skills of the next generation of healthcare professionals. It gives educators the trusted healthcare education software needed to teach and assess clinical content and behavioral approaches to complex clinical problems. It supports medical schools in delivering secure, scalable, rigorous and cost effective OSCEs, or objective structured clinical examinations, on campus or remotely. It reduces administrative and faculty time and workload, improves objectivity, offers built-in educational and remediation support and boosts evaluation consistency.
"The MES represents a meaningful step forward in the evolution of medical education," said Claudio Violato, professor and assistant dean, Assessment, Evaluation and Research at the University of Minnesota (UMN) Medical School.
The UMN Medical School recently deployed Treatment's new MES live with 240 third-year students, and it was successful. The exams ran with complete technical reliability and integrated seamlessly into the school's existing OSCE workflow. According to UMN, use of the MES reduced its administrative cost by about 40%.
"Early feedback suggests that the platform enhances the student learning experience and strengthens the reliability of OSCE results," the release noted.
UMN's live deployment was the first large-scale implementation of computer-simulated patient cases developed through Treatment.com's Global Library of Medicine (GLM), a medical knowledge engine developed using internal algorithms and the input of hundreds of healthcare professionals around the world.
Preliminary results of GLM's accuracy and precision as applied in the MES platform were presented at the Association of American Medical Colleges' 2025 Group on Information Resources meeting. Treatment.com Founder and Chief Medical Officer Dr. Kevin Peterson, Violato and their respective teams are preparing further scientific publications detailing the methodology, deployment and outcomes of the University of Minnesota program.
"The MES allowed us to deliver a high-stakes OSCE at scale while ensuring consistent, objective evaluation aligned with our academic standards," Violato added.
This platform reflects years of development in diagnostic reasoning and knowledge engineering. It incorporates curated AI-generated cases alongside live simulated patients and provides automated feedback and objective real-time scoring. This helps faculty assess students' diagnostic and management reasoning, clinical prioritization and documentation quality. It aligns with LCME (Liaison Committee on Medical Education) standards.
Treatment.com AI is working to get the MES into additional schools in North America, the United Kingdom and other international OSCE markets.
Transforming Healthcare with AI
Treatment.com AI Inc., based in British Columbia, is on a mission to transform healthcare globally into a system based on trusted medical intelligence. To this end, it leverages AI, machine learning and best clinical practices with the goal of improving healthcare by delivering precise medical insights, assisting various types of providers and students, and eradicating inefficiencies.
There are three key components to Treatment.com's digital healthcare offerings, according to its Investor Presentation. One is the GLM, the proprietary, accurate medical knowledge base of most of the company's offerings, including AI Patient, AI Doctor in a Pocket and AI Pharmacy Assist.
Consistently updating and improving, the GLM contains about 10,000+ expert medical reviews, diagnoses for 1,000-plus diseases and 15,000-plus symptoms. It suggests appropriate lab tests and imaging, treatment options and billing codes. The GLM has been designed to be integrated through APIs, in a plug-and-play fashion, into a variety of platforms or organizations.
The GLM is designed to help healthcare professionals (physicians, nurses and/or pharmacists) lessen their administrative burden. It creates more time for effective face-to-face patient appointments and aims to make the quality of patient support more consistent.
The second pillar of Treatment's offerings is AI-powered triage, as an example effected through Treatment.com's emerging AI-Voice Assistant. This combines conversational AI and voice technology to improve patient interactions through various processes like onboarding. Treatment envisages the AI-Voice Assistant helping expand access to care support post discharge and for mental health.
The third element is virtual care tools, through its subsidiary Rocket Doctor, a digital healthcare platform and marketplace. Described as "Shopify for physicians," the platform allows providers to deliver smarter, faster and safer care, remotely or not, with a focus on underserved communities across North America. Earlier this month, Rocket Doctor was chosen, along with 14 other companies, to be part of this year's Heal.LA, a program by the nonprofit organization Larta Institute that supports and promotes innovative bioscience and healthcare startups working to close care gaps in underserved communities in Los Angeles, Calif.
Catalyst: Rising Use of AI in Education
The integration of AI in healthcare education is "pivotal," altering and enhancing the ways curricula are taught and the ways students learn, described Cameron Putty in a blog post on thoughtful.ai. For instance, as with Treatment.com's MES, AI provides interactive patient and scenario simulations and real-time feedback that allows students to develop their clinical skills. AI helps students improve their diagnostic assessments and decision-making. AI tailors content to students' specific needs. Use of AI in the classroom and lab readies students for working with AI tools in the field.
"Traditional learning models, often characterized by one-size-fits-all approaches and theoretical knowledge, are gradually giving way to more dynamic, interactive and personalized educational experiences powered by AI," Putty wrote. "AI-enabled healthcare education represents a significant step forward in training the next generation of healthcare providers."
AAMCNews purported that more and more U.S. medical schools are incorporating AI into their educational programs, in part "to create quizzes, simulate patients, pinpoint student struggles and write assessments."
Healthcare education around the world is growing, which bodes well for the AI in healthcare education segment. According to a January S&S Insider report, the global healthcare education market is forecasted to expand at an 11% compound annual growth rate between 2024 and 2032, reaching US$280.6 billion (US$280.6B) in value from US$110B. The report attributes current and future growth to advancements in AI, e-learning and virtual reality technologies.
When it comes to the even broader global market, the use of AI in healthcare, it too is growing. Research and Markets predicts it will experience a 38.6% CAGR between 2025 and 2030. During this period, the market is projected to quintuple in value, reaching US$111B from US$22B. Increasing AI integration is a growth driver, as are advancements in human-aware AI systems and investments from the public and private sectors.
Also fueling growth, according to Precedence Research, are the rising demand for personalized medicine, the reduced costs and the greater efficiency that result from the use of AI and improved patient outcomes. On the flip side, hindrances to market expansion include concerns about data privacy and security as well as regulatory and ethical issues.
Analyst: Stock Ready to Break Out
In a May 21 report, Technical Analyst Clive Maund highlighted Treatment.com's technologies and both Treatment and Rocket Doctor's relationships with major medical organizations in the U.S. and Canada.
"Treatment.com AI is positioning to be a major player in the AI transformation of healthcare," Maund wrote. "This being so, I believe the outlook for the company and its stock is very bright indeed."
Treatment.com's charts show that a large base pattern has been forming since late 2022. While this was happening, the 200-day moving average dropped to a level near the price. This generally occurs before a new bull market.
"This [base] pattern now looks mature," the analyst added. "Given the extraordinarily bright prospects for the company, the time is believed to be at hand for the stock to advance, to break out above the key resistance."
As such, it is a good time to buy or add to positions, Maund pointed out. He noted the first target range for an advance is CA$1.08–1.12, the second, CA$4, with much higher targets possible later. In comparison, Treatment.com's share price was CA$0.40 at mid-day on June 12.
Ownership and Share Structure
According to Refinitiv, as of June 12, 2025, insider and institutional ownership of Treatment.com AI totals 5.91%. Co-founder and Chief Medical Officer Dr. Kevin Peterson is the majority shareholder with 5.09%. Institutional investors are Palos Management Inc. and StoneCastle Investment Management Inc. The rest is in retail.
The healthcare tech company has 75.5 million (75.5M) outstanding shares and 71.65M free float traded shares. Its market cap is CA$21.82 million. Its 52-week range is CA$0.33–1.11 per share.
| Want to be the first to know about interesting Technology investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. | Subscribe |
